FDA clears pTau217 blood test for Alzheimer's disease
-
By
-
Kathryn Wighton
-
August 24, 2026
-
2 min
By
Kathryn Wighton
August 24, 2026
Quasi-experimental analysis of nearly 900,000 emergency department visits found no evidence of lower mortality among admitted patients.
June 9, 2026
Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.
May 5, 2026
NHANES analysis shows inverse dose-response associations for omega-3 and omega-6 intake, with no link for fatty acid ratio
April 28, 2026